Y-90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?

Yilmaz E., Engin M. N., Oezkan Z. G., Kovan B., Bueyuekkaya F., Poyanli A., ...Daha Fazla

NUCLEAR MEDICINE COMMUNICATIONS, cilt.41, sa.12, ss.1242-1249, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 12
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1097/mnm.0000000000001284
  • Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1242-1249
  • Anahtar Kelimeler: Lu-177-octreotate, Y-90 microspheres, neuroendocrine tumors, peptide receptor radionuclide therapy, selective internal radiation therapy, RADIOEMBOLIZATION, LU-177-DOTATATE, MICROSPHERES, EFFICACY, NETS
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background